DHP Korea Co., Ltd. (131030.KQ) — Stock Score Summary

DHP Korea Co., Ltd. (131030.KQ) has a MoatMap StockRank of 79/100 based on Quality (64/100), Value (61/100), and Momentum (38/100) factor scores. The current signal is BUY.

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products.

Key Financial Metrics

Price$3.73
Market Cap$59M
P/E (TTM)7.76
Price/Book0.53
Return on Equity7.9%
Return on Invested Capital6.7%
Debt/Equity0.78
Gross Margin55.4%
Operating Margin12.5%
Revenue Growth23.8%
Free Cash Flow$-16K

DHP Korea Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is DHP Korea Co., Ltd.’s (131030.KQ) StockRank?
MoatMap’s StockRank for DHP Korea Co., Ltd. (131030.KQ) is 79/100, with a Buy signal. It is a composite of Quality (64), Value (61), and Momentum (38) factor ranks across MoatMap’s 19,000+ stock universe.
Does DHP Korea Co., Ltd. have an economic moat?
DHP Korea Co., Ltd. (131030.KQ) has a Quality factor score of 64/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is DHP Korea Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for DHP Korea Co., Ltd. (131030.KQ) is Buy, based on a StockRank of 79/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is DHP Korea Co., Ltd. in?
DHP Korea Co., Ltd. (131030.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).